| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | RVI BIOTECNOLOGÍA | 71,282272 | 19/05/2026 | -0,87% | -3,89% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 69,850000 | 19/05/2026 | -1,03% | -4,20% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 69,100000 | 19/05/2026 | -2,53% | -1,55% | ** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | MIXTO AGRESIVO GLOBAL | 144,840000 | 19/05/2026 | 8,19% | 36,68% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | MIXTO AGRESIVO GLOBAL | 144,655766 | 19/05/2026 | 8,32% | 36,76% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | MIXTO AGRESIVO GLOBAL | 104,460000 | 19/05/2026 | 8,18% | 24,59% | ** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | MIXTO AGRESIVO GLOBAL | 103,250000 | 19/05/2026 | 5,20% | 15,35% | * |
| JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | MIXTO AGRESIVO GLOBAL | 164,680000 | 19/05/2026 | 8,50% | 39,78% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | MIXTO AGRESIVO GLOBAL | 133,380000 | 19/05/2026 | 7,92% | 34,04% | **** |
| JPM TOTAL EMERGING MARKETS INCOME D (ACC) USD | MIXTO AGRESIVO GLOBAL | 133,321859 | 19/05/2026 | 8,06% | 34,12% | **** |
